Illumina to buy healthcare company GRAIL for $8bn
Illumina currently owns 14.5% of GRAIL’s shares outstanding. (Credit: Colin Behrens from Pixabay)
NS Medical Devices is using cookies
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X